Dymista FDA Approval History
FDA Approved: Yes (First approved May 1, 2012)
Brand name: Dymista
Generic name: azelastine and fluticasone
Dosage form: Nasal Spray
Company: Meda Pharmaceuticals, Inc.
Treatment for: Allergic Rhinitis
Dymista (azelastine and fluticasone) nasal spray is an H1-receptor antagonist and corticosteroid combination indicated for the relief of symptoms of seasonal allergic rhinitis.
Development Timeline for Dymista
|May 2, 2012||MEDA Announces Dymista Approved by the FDA|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.